LANCET HAEMATOL 润色咨询

Lancet Haematology

出版年份：2014 年文章数：283 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：3.0% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=588863, encodeId=5eac58886302, content=请问这个期刊收机制研究的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=582, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211208/22a3084af9a846fab54e5c73fa504f6e/d0434724da834fbda3d95ddcd01c5f3a.PNG, createdBy=ca9a2193900, createdName=1209ce3em25(暂无昵称), createdTime=Tue Apr 14 22:25:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106270, encodeId=d65711062e03b, content=想要做但未做的实验是否可以放到讨论中？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106269, encodeId=1ad4110626902, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588768, encodeId=ce6d588e68cb, content=请问这个杂志接收机制研究文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=550, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211208/22a3084af9a846fab54e5c73fa504f6e/d0434724da834fbda3d95ddcd01c5f3a.PNG, createdBy=ca9a2193900, createdName=1209ce3em25(暂无昵称), createdTime=Mon Apr 13 16:56:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578773, encodeId=e46e5e877330, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=595, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547560, encodeId=760a54e560e1, content=审稿速度:1.0<br>经验分享：对临床试验要求很严格，审稿快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=772, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49402157183, createdName=肥而不腻, createdTime=Sun Sep 24 11:02:00 CST 2017, time=2017-09-24, status=1, ipAttribution=)]
    2020-04-14 1209ce3em25(暂无昵称)

    请问这个期刊收机制研究的文章吗？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=588863, encodeId=5eac58886302, content=请问这个期刊收机制研究的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=582, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211208/22a3084af9a846fab54e5c73fa504f6e/d0434724da834fbda3d95ddcd01c5f3a.PNG, createdBy=ca9a2193900, createdName=1209ce3em25(暂无昵称), createdTime=Tue Apr 14 22:25:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106270, encodeId=d65711062e03b, content=想要做但未做的实验是否可以放到讨论中？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106269, encodeId=1ad4110626902, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588768, encodeId=ce6d588e68cb, content=请问这个杂志接收机制研究文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=550, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211208/22a3084af9a846fab54e5c73fa504f6e/d0434724da834fbda3d95ddcd01c5f3a.PNG, createdBy=ca9a2193900, createdName=1209ce3em25(暂无昵称), createdTime=Mon Apr 13 16:56:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578773, encodeId=e46e5e877330, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=595, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547560, encodeId=760a54e560e1, content=审稿速度:1.0<br>经验分享：对临床试验要求很严格，审稿快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=772, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49402157183, createdName=肥而不腻, createdTime=Sun Sep 24 11:02:00 CST 2017, time=2017-09-24, status=1, ipAttribution=)]
    2021-12-28 rayms

    想要做但未做的实验是否可以放到讨论中？

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=588863, encodeId=5eac58886302, content=请问这个期刊收机制研究的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=582, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211208/22a3084af9a846fab54e5c73fa504f6e/d0434724da834fbda3d95ddcd01c5f3a.PNG, createdBy=ca9a2193900, createdName=1209ce3em25(暂无昵称), createdTime=Tue Apr 14 22:25:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106270, encodeId=d65711062e03b, content=想要做但未做的实验是否可以放到讨论中？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106269, encodeId=1ad4110626902, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588768, encodeId=ce6d588e68cb, content=请问这个杂志接收机制研究文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=550, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211208/22a3084af9a846fab54e5c73fa504f6e/d0434724da834fbda3d95ddcd01c5f3a.PNG, createdBy=ca9a2193900, createdName=1209ce3em25(暂无昵称), createdTime=Mon Apr 13 16:56:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578773, encodeId=e46e5e877330, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=595, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547560, encodeId=760a54e560e1, content=审稿速度:1.0<br>经验分享：对临床试验要求很严格，审稿快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=772, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49402157183, createdName=肥而不腻, createdTime=Sun Sep 24 11:02:00 CST 2017, time=2017-09-24, status=1, ipAttribution=)]
    2021-12-28 Gym璨烨

    模式图一般放在讨论中展示还是放在结果部分？

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=588863, encodeId=5eac58886302, content=请问这个期刊收机制研究的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=582, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211208/22a3084af9a846fab54e5c73fa504f6e/d0434724da834fbda3d95ddcd01c5f3a.PNG, createdBy=ca9a2193900, createdName=1209ce3em25(暂无昵称), createdTime=Tue Apr 14 22:25:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106270, encodeId=d65711062e03b, content=想要做但未做的实验是否可以放到讨论中？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106269, encodeId=1ad4110626902, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588768, encodeId=ce6d588e68cb, content=请问这个杂志接收机制研究文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=550, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211208/22a3084af9a846fab54e5c73fa504f6e/d0434724da834fbda3d95ddcd01c5f3a.PNG, createdBy=ca9a2193900, createdName=1209ce3em25(暂无昵称), createdTime=Mon Apr 13 16:56:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578773, encodeId=e46e5e877330, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=595, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547560, encodeId=760a54e560e1, content=审稿速度:1.0<br>经验分享：对临床试验要求很严格，审稿快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=772, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49402157183, createdName=肥而不腻, createdTime=Sun Sep 24 11:02:00 CST 2017, time=2017-09-24, status=1, ipAttribution=)]
    2020-04-13 1209ce3em25(暂无昵称)

    请问这个杂志接收机制研究文章吗？

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=588863, encodeId=5eac58886302, content=请问这个期刊收机制研究的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=582, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211208/22a3084af9a846fab54e5c73fa504f6e/d0434724da834fbda3d95ddcd01c5f3a.PNG, createdBy=ca9a2193900, createdName=1209ce3em25(暂无昵称), createdTime=Tue Apr 14 22:25:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106270, encodeId=d65711062e03b, content=想要做但未做的实验是否可以放到讨论中？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106269, encodeId=1ad4110626902, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588768, encodeId=ce6d588e68cb, content=请问这个杂志接收机制研究文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=550, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211208/22a3084af9a846fab54e5c73fa504f6e/d0434724da834fbda3d95ddcd01c5f3a.PNG, createdBy=ca9a2193900, createdName=1209ce3em25(暂无昵称), createdTime=Mon Apr 13 16:56:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578773, encodeId=e46e5e877330, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=595, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547560, encodeId=760a54e560e1, content=审稿速度:1.0<br>经验分享：对临床试验要求很严格，审稿快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=772, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49402157183, createdName=肥而不腻, createdTime=Sun Sep 24 11:02:00 CST 2017, time=2017-09-24, status=1, ipAttribution=)]
    2019-10-25 147612bem32暂无昵称

    求经验求分享

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=588863, encodeId=5eac58886302, content=请问这个期刊收机制研究的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=582, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211208/22a3084af9a846fab54e5c73fa504f6e/d0434724da834fbda3d95ddcd01c5f3a.PNG, createdBy=ca9a2193900, createdName=1209ce3em25(暂无昵称), createdTime=Tue Apr 14 22:25:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106270, encodeId=d65711062e03b, content=想要做但未做的实验是否可以放到讨论中？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106269, encodeId=1ad4110626902, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588768, encodeId=ce6d588e68cb, content=请问这个杂志接收机制研究文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=550, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211208/22a3084af9a846fab54e5c73fa504f6e/d0434724da834fbda3d95ddcd01c5f3a.PNG, createdBy=ca9a2193900, createdName=1209ce3em25(暂无昵称), createdTime=Mon Apr 13 16:56:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578773, encodeId=e46e5e877330, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=595, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547560, encodeId=760a54e560e1, content=审稿速度:1.0<br>经验分享：对临床试验要求很严格，审稿快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=772, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49402157183, createdName=肥而不腻, createdTime=Sun Sep 24 11:02:00 CST 2017, time=2017-09-24, status=1, ipAttribution=)]
    2017-09-24 肥而不腻

    审稿速度:1.0
    经验分享：对临床试验要求很严格，审稿快

    0

共12条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分